News
A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...
The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...
China: A new meta-analysis published in Annals of Medicine has identified elevated C-reactive protein (CRP) levels as a ...
Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.
Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.
TIL-IMP therapy offers sustained QoL benefits over ipilimumab in advanced melanoma, supporting its role in personalized care.
A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by ...
MoleMap take high-resolution photos of customers’ bodies to map, diagnose and monitor the development of lesions – in an ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
1d
News Medical on MSNAI assistance improves accuracy and consistency in skin cancer tissue analysisPathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...
13d
News-Medical.Net on MSNMelanoma’s excessive mitochondrial dependence becomes a therapeutic vulnerabilityResearchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key ...
A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results